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Crystal structure of tripartite-type ABC transporter
MacB from Acinetobacter baumannii
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The MacA–MacB–TolC tripartite complex is a transmembrane machine that spans both
plasma membrane and outer membrane and actively extrudes substrates, including macro-
lide antibiotics, virulence factors, peptides and cell envelope precursors. These transport
activities are driven by the ATPase MacB, a member of the ATP-binding cassette (ABC)
superfamily. Here, we present the crystal structure of MacB at 3.4-Å resolution. MacB forms
a dimer in which each protomer contains a nucleotide-binding domain and four transmem-
brane helices that protrude in the periplasm into a binding domain for interaction with the
membrane fusion protein MacA. MacB represents an ABC transporter in pathogenic
microorganisms with unique structural features.
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Multidrug resistance caused by export proteins is a ser-ious problem in antibiotic treatment of numerousbacterial infections1. The envelope of Gram-negative
pathogens, such as Acinetobacter baumannii and Pseudomonas
aeruginosa, contains unique tripartite machineries that export
noxious compounds from the cell. These machineries are com-
posed of a plasma membrane transporter and outer membrane
porin (OMP) that are connected by a periplasmic adaptor pro-
tein2. Proton motive force-dependent tripartite multidrug efﬂux
transporters belonging to the resistance-nodulation-cell division
(RND) transporter family have been well characterized3, 4. ABC
family and major facilitator superfamily transporters can also be
part of tripartite complexes, and share similar or identical com-
ponents with RND transporters, but their structures are still
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Fig. 1 Measurement of drug resistance of E. coli expressing A. baumannii MacA-MacB-TolC or transport inactive mutants. a Growth of E. coli expressing
Acinetobacter MacAB-TolC, or combinations of components and mutants, in the presence of various macrolides and AcrB substrates. Data in Table 1 are
based on the colony formation shown in this ﬁgure. A, MacA; B, native MacB; B(E172Q), transport-inactive E172Q MacB mutant; B(ΔC10), MacB lacking
the carboxy terminal CH2; C, TolC. For MIC measurements, cells were grown on agar plates in the presence of dilutions of compounds. Abbreviations of
drugs are the same as in Table 1. b Expression of MacA-MacB-TolC confers drug resistance on E. coli cells in liquid cultures. Relative growth rate of drug-
sensitive E. coli W3104 ΔacrABΔmacAB harbouring empty pBAD vector (control), or pBAD containing macAB/tolC from A. baumannii (blue trace), or pBAD
with macA/tolC only (inactive; red trace) in the presence of (left) 0–2.3 µg ml−1 azithromycin or (right) 0–56.4 µgml−1 roxithromycin. IC50 values are
summarized in Table 2. Each measurement was repeated three times
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/s41467-017-01399-2
2 NATURE COMMUNICATIONS | 8:  1336 |DOI: 10.1038/s41467-017-01399-2 |www.nature.com/naturecommunications
unknown5, 6. Crystal structures of ABC transporters have been
reported for various organisms for both substrate exporters and
importers7, 8. In type I bacterial ABC exporters for antibiotics and
cytotoxic agents, the minimum functional unit has two trans-
membrane domains (TMDs) and two cytosolic nucleotide-
binding domains (NBDs). One TMD is often fused to one NBD
on a single polypeptide that assembles into a homodimer or
heterodimer to form a functional unit. The TMDs can contain six
transmembrane helices (TMs) per monomer, but two helices out
of six are combined with four helices of the second half-trans-
porter, thus enlarging the dimer interface and providing a tight
interaction between the monomers during transport. The TMs
are extended at the cytosolic side, forming intracellular domains
that interact with NBDs via coupling helices (CHs)9–12.
The tripartite MacA-MacB-TolC transporter in Gram-negative
bacterial pathogens including Escherichia coli, Neisseria gonor-
rhoeae, P. aeruginosa, Vibrio cholerae, Klebsiella pneumoniae,
Yiersinia pestis and A. baumannii5, 13 is an important efﬂux
pump that mediates the extrusion of macrolides14, peptide tox-
ins15, virulence factors16, siderophores17, lipopolysaccharides18
and protoporphyrins19. MacA-MacB-TolC contains similar
components as the relatively well-characterized tripartite RND
transporters AcrA-AcrB-TolC in E. coli and MexA-MexB-OprM
in P. aeruginosa. The membrane fusion protein (MFP) MacA is
homologous to AcrA and MexA, whereas the OMP TolC is
shared by both RND and ABC tripartite systems in E. coli, and is
homologous to OprM20. However, the ABC protein MacB is
unrelated to AcrB and MexB, which form large trimeric com-
plexes in the plasma membrane, raising questions about the
structure and domain organization of MacB in the tripartite efﬂux
pump. Here, we present the crystal structure of MacB, and show
that, by analogy to RND transporters, the MacB homodimer
contains two large periplasmic domains (PLDs) that enable the
interactions with the other components in this tripartite efﬂux
pump.
Results
Overall structure of MacB. The ABC exporter MacB from A.
baumannii was functionally expressed in E. coli (Fig. 1, Tables 1,
2, Supplementary Figs. 1 and 14). MacB was puriﬁed and its
crystal structure was solved at 3.4-Å resolution (Fig. 2a–e,
Table 3, Supplementary Fig. 2). A non-critical polypeptide seg-
ment between position 248 and 259 at the exterior of the NBD
was found to be disordered. MacB shares 83% amino-acid
sequence similarity (53% identity) with well-studied MacB from
E.coli (Fig. 3a) and has a domain arrangement similar to yeast
PDR521 and mammalian ABCG transporters22 with an N-
terminal NBD followed by a C-terminal TMD (Fig. 3b). Two
MacB monomers have a biological twofold rotation axis at the
centre of the dimer. Each monomer in the dimer has essentially
an identical structure (~1.1-Å RMSD in Cα position), and has
elongated TMs (TM1 and TM2) protruding about 25 Å at the
periplasmic side of the phospholipid bilayer (Fig. 2, Supplemen-
tary Fig. 3). The distal end of these TMs forms the PLD (Fig. 3c,
Supplementary Fig. 3) that is important for the interaction with
the MFP MacA23. The interface between the monomers in the
MacB dimer is extensive (2188.9 Å2) with major contributions
from the TMDs (1053.0 Å2, 48%), PLDs (676.1 Å2, 31%) and
NBDs (417.0 Å2, 19%). Although MacB shares structural motifs
with other members of the ABC superfamily, its architecture is
unique among transporters of known structures (Fig. 2f).
Nucleotide-binding domain. MacB was crystallized in the pre-
sence of adenosine-5′-(β-thio)-diphosphate (ADPβS) (Fig. 4a, b,
Supplementary Fig. 4). The two NBDs are dimerized in a head-to-
tail arrangement, and both subunits contribute conserved Walker
A, Walker B and ABC signature motifs and residues to form two
composite nucleotide-binding sites at the dimer interface. Elec-
tron density was observed in the difference Fourier map (Fig. 4a,
b) at the expected position for the nucleotide-binding site.
Although the shape of the difference Fourier map is not optimally
ﬁtted by the ADPβS model, the phosphor and sulphur atoms of
the bound ADPβS are clearly identiﬁed in the anomalous dif-
ference Fourier map (7σ, 0.013 electron Å−3) (Fig. 4a, b, Sup-
plementary Fig. 5). The binding of the adenine moiety of the
nucleotide involves a π-stacking interaction with a conserved
aromatic residue (Phe16) in the A-loop of the NBD (Fig. 4b,
Supplementary Fig. 4)24. When compared with crystallized
nucleotide-bound and apo states of various ABC exporters
Table 1 Measurement of drug resistance of E. coli expressing A. baumannii MacA-MacB-TolC or transport inactive mutants
Component(s) expressed MIC (μg ml−1)
Macrolide (MacB substrates) AcrB substrates
EM CAM RXM AZM SPM LM ACR SDS
None (empty vector) 1.56 1.56 4.41 0.55 4.41 2.2 4.41 50.0
MacA-MacB(E172Q)-TolC 1.10 1.56 1.56 0.39 4.41 1.10 4.41 50.0
MacA-MacB-TolC 2.21 2.21 6.25 0.55 6.25 3.13 4.41 50.0
MacA-MacB 1.56 2.21 1.56 0.28 4.41 1.10 4.41 50.0
MacA-TolC 1.10 1.56 1.56 0.28 2.21 1.10 4.41 50.0
MacB-TolC 1.56 1.56 1.56 0.28 4.41 1.10 4.41 50.0
MacA-MacB(ΔC10)-TolC 0.78 1.10 1.56 0.28 2.21 1.10 4.41 50.0
EM, erythromycin; CAM, clarithromycin; RXM, roxithromycin; AZM, azithromycin; SPM, spiramycin; LM, leucomycin; ACR, acriﬂavine; SDS, sodium dodecyl sulfate
The resistance levels are shown as minimum inhibitory concentration (MIC) in µgml−1determined by the agar dilution method. Values are based on data shown in Fig. 1. Cells expressing the inactive Walker B
E172Q MacB mutant were used as a negative control rather than non-expressing cells that lack the expression of foreign protein. Drug resistance is restored by expression of the functional MacA-MacB-TolC
tripartite complex. AcrB substrates acriﬂavine and SDS are not transported by MacA-MacB-TolC. The MacB mutant lacking the carboxy-terminal coupling helix, CH2 is abbreviated as MacB(ΔC10)
Table 2 IC50 values determined in the growth experiments in
Fig. 1b with E. coli expressing A. baumannii Mac and TolC
proteins
Macrolide IC50 (μgml−1)
Control MacA/TolC MacAB/TolC
Azithromycin 0.9 0.9 1.5
Roxithromycin 21.8 23.3 39.3
The mean concentrations of antibiotic that reduce the relative growth rate by 50% (IC50) in
three independent experiments are presented in the table
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(Fig. 4c, Supplementary Table 1), the arrangement of the two
NBDs in the MacB dimer is most similar to the arrangement of
the NBDs in the ADP-bound outward-occluded state of the lipid-
linked oligosaccharide ﬂippase PglK25.
Transmembrane domain structure. The TMD of MacB
encompasses four TMs per monomer, which is the smallest
number among currently characterized ABC exporters7. The TMs
are not swapped between the half-transporters (Fig. 2f) and lack
the helical extensions into intracellular domains as found in most
type-I ABC exporters. MacB shares this property with ABC
importers and the type-II exporter ABCG5/G826 and ABCG227.
Even though the MacB monomer has only one cytoplasmic loop,
MacB preserves two CHs as observed in other ABC exporters.
CH1 is present in the intracellular loop between TM2 and TM3,
whereas CH2 is located in the carboxy terminus of MacB
(Fig. 3b). Unlike Sav1866 and MsbA, in which CH1 contacts the
NBDs of respective monomers and CH2 interacts with the NBD
of the opposite monomer exclusively9, 10, the two CHs in MacB
only contact one NBD within the same monomer. However, even
though the CHs in MacB are topologically different and the
arrangement of connected TMs shares no similarity with any
other bacterial exporter, the placement of the two CHs on the
NBD surface is quite similar to the arrangement found in crys-
tallized ABC exporters (Fig. 5, Supplementary Fig. 6, Supple-
mentary Movie 1).The positions of the CHs and their interactions
with the NBDs are similar, but the connecting TMs are com-
pletely different. Furthermore, the order of the CHs is opposite
due to the topological differences (Fig. 5b–d, Supplementary
Fig. 6). Removal of CH2 by truncation of the carboxy terminus of
MacB leads to inactivation of drug export (Fig. 1a, Table 1,
Supplementary Figs. 7 and 14), demonstrating the importance of
the CHs for functionality. Furthermore, a loop connects the TMD
at its N-terminus to the NBD. This loop contains an amphiphilic
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Fig. 2 Crystal structure of MacB in ribbon representation. a, bMacB homodimer viewed parallel to the membrane plane in two orientations, rotated by 90°
around a vertical axis to the membrane plane. The two protomers are individually coloured (red and green). Dotted lines depict the approximate membrane
boundaries on the basis of the hydrophobicity of the protein surface and position of the elbow helix (Supplementary Fig. 3). c Top view on PLD domains
from periplasmic space. d Cut view of the TMD parallel to the membrane plane. TMs are numbered. e Bottom view on NBDs from cytoplasm. f Comparison
with major classes of ABC transporters in different states shows that the MacB structure (in green) is unique. From left to right: type-I (B-family) exporter
TM287/288 heterodimer from Thermotoga maritima in inward-open state (PDB accession code 3QF4)11, type-I (B-family) exporter McjD from E. coli in
outward-occluded state (PDB accession code 4PL0)12, type-I (B-family) exporter Sav1866 from Staphylococcus aureus in outward-open state (PDB
accession code 2HYD)9, lipid-linked oligosaccharide ﬂippase PglK from Campylobacter jejuni in outward-occluded state (PDB accession code: 5C73)25,
type-II exporter human ABCG5/ABCG8 (PDB accession code: 5DO7)26, MacB from A. baumannii (PDB accession code: 5WS4), type-I importer ModBC
from Archaeoglobus fulgidus (PDB accession code: 2ONK)55 and type-II importer BtuCD from E. coli (PDB accession code: 2QI9)56. Half-transporters are
shown in dark and pale colours to highlight the exchange of TMs in some ABC transporters, but not in the MacB dimer
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Fig. 3 Sequence conservation among MacB proteins, secondary and tertiary structures of Acietobactor MacB. a Amino acid sequence alignment of MacB from A.
baumannii with ﬁve MacB orthologues from Actinobacillus actinomycetemcomitans (Aggregatibacter actinomycetemcomitans), Bacillus amyloliquefaciens, E. coli, P.
aeruginosa and N. gonorrhoeae. Alignment was generated with the ClustalW multiple sequence alignment tool57. Strictly conserved and highly conserved residues are
highlighted in red boxes and red lettering, respectively. Major secondary structure elements are shown on top as coils and arrows for α-helices and β-strands,
respectively. Labelling of the secondary structure elements in NBD are according to convention58. Alignment was displayed using ESPript 3.0 (http://espript.ibcp.fr/
ESPript/ESPript/)59. b Topology diagram of MacB monomer. Secondary structure elements are indicated with the same annotation as in (a). Dotted line shows a
disordered polypeptide segment at position 248–259. Designated motifs in NBD are indicated. N and C refer to amino- and carboxy-terminus, respectively. Walker-
A, Walker-B, C-loop, D-loop, Q-loop, Gly-loop and Switch-loop are conserved sequence elements in ABC NBDs. cMonomer structure of MacB in two orientations,
rotated by 90° around a vertical axis to the membrane plane. In b and c, following colouring is used: NBD in magenta; TMD containing TM1, TM2, TM3 and TM4 in
blue, green, yellow and red, respectively; PLD in cyan; elbow in purple. Coupling helix 1 (CH1) between TM2 and TM3 in green. C-terminal CH2 in red. Dotted black
lines depict the approximate membrane boundaries on the basis of the hydrophobicity of the protein surface and location of elbow helix. TMs, transmembrane
helices; Nα and Nβ, helices and strands in NBD; Pα and Pβ, helices and strands in PLD; Elbow elbow helix, CH, coupling helix
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α-helix running parallel to the cytosolic surface of the plasma
membrane in which it is partially embedded (Fig. 3b, Supple-
mentary Fig. 3). This helix is equivalent to the ‘elbow helix’ in
many other ABC exporters, and is also observed in a similar
location as the ‘connecting helix’ in the heterodimeric ABCG-type
exporter ABCG5/ABCG8 (Fig. 2f)26. Finally, the PLD of MacB
has a similar overall structure as the crystallized isolated PLD
derived from Actinobacillus MacB (r.m.s. deviation of Cα-
positions of 2.2 Å over 214 residues)28 and YknZ, a homologue
from Bacillus amyloliquefaciens (r.m.s. deviation of Cα-positions
of 2.3 Å over 187 residues)29, except for one loop region con-
taining α-helix, Pα1 (Supplementary Fig. 8). The variable struc-
ture of the loop containing Pα1 might point to molecular
movements during catalytic activity at the NBDs, and propaga-
tion of these movements to MacA and TolC in the transport
process. Given the differences in the number of TMs and their
interactions in MacB compared to other ABC transporters, and
the presence and structure of periplasmic extensions of TM1 and
TM2 forming the PLDs, we conclude that the fold of MacB is
unique among known structures of ABC exporters (Fig. 2f).
When MacB is compared with outward-facing structures of
MsbA and Sav1866, which participate in alternating access
mechanisms for these transporters, the overall structure provides
a similar V-shape opening with access to the periplasm(Fig. 6,
Supplementary Movie 2). However, the locations of these
openings are different. The cavity in Sav1866 is present in the
outer leaﬂet of the phospholipid bilayer, whereas the cavity in
MacB is present in the periplasmic space. The TMD of MacB does
not exhibit a distinct cavity in the membrane-embedded sections
of the TMs (Supplementary Fig. 9), suggesting that a substrate-
binding pocket might not exist in this part of MacB. This notion
is further corroborated in a search of structural similarities
between the TMD of MacB and other membrane proteins using
the fold match program DALI30, 31. Surprisingly, the ﬁrst
30 signiﬁcant hits all correspond to ABC transporters. In
particular, the arrangement of TM1, 2 and 3 (H282-L321,
N521-567T and A578-F616) at the dimer interface of the MacB
dimer shows a similarity with the organization of TM1, 2 and 3
(V33-T211) in the mouse multidrug resistance P-glycoprotein
ABCB1a (PDB accession code: 4M1M)32 (Fig. 7, Supplementary
Table 2). In the DALI pairwise comparison, the resulting Z-score
of 8.0 (RMSD= 4.1) suggests that these regions share a similar
protein structure motif (Fig. 7)31. The dimer interface in MacB is
not matched with the dimer interface of ABCB1a. Instead, TM1, 2
and 3 in ABCB1a are located at the side of the transporter in a
region that faces the phospholipid bilayer, and that is important
for conformational changes during transport (Fig. 7c). Similarly,
MacB’s TM1, 2 and 3 are not part of a substrate-binding cavity in
the membrane (Supplementary Fig. 9), and might therefore play
an analogous role in energy transduction rather than in substrate
interactions. In agreement with this view one of MacB’s
endogenous substrates, the heat stable enterotoxin II, is matured
from precursors in the periplasm and therefore most likely
extruded by MacA-MacB-TolC from the periplasm rather than
membrane or cytosol15. It is also noteworthy that the MacB PLD
shares structural similarity with the PLD LolE in the lipoprotein
transport system LolCDE (Z= 15.7, RMSD= 3.8) (Supplemen-
tary Figs. 10–12)33, which transfers lipoproteins from the outer
leaﬂet of the inner membrane to the periplasmic carrier protein
LolA33. Furthermore, MacB PLD is similar to the PLD of AcrB (Z
= 7.8, RMSD= 9.0)28 for which substrate transport from the
periplasm has been demonstrated2 (Supplementary Fig. 13).
Thus, MacB might capture substrates from the periplasm. Further
structural information about inward-facing states might provide
clues regarding the possibility that MacB can also transport
substrates from the cytoplasm.
Discussion
In the AcrAB-TolC and MexAB-OprM assemblies, the proton
motive force-dependent functional rotation of the trimetric AcrB
and MexB components at the inner membrane is tightly coupled
to conformational changes in the PLDs, which in turn drive
periplasmic transport of substrate via AcrA/MexA and TolC/
OprM34. In MacB, the tight coupling between NBD and TMD via
CH1 and CH2 will not only be used for movement of TMs but
will also be critical for long-range communication with the PLDs
that are required for transport of substrate via MacA and TolC.
The signiﬁcant differences in size of the trimeric AcrB and MexB
vs.dimeric MacB in otherwise homologous tripartite assemblies
raise interesting questions about the stoichiometry of the com-
ponents in the MacA-MacB-TolC complex35. Given the diversity
in size and chemical properties of MacB substrates, it will also be
interesting to study the mechanisms of substrate binding and
transport by the transporter complex. Our crystal structure pro-
vides a framework for these and other studies on MacB and
related ABC exporters in Gram-negative pathogenic bacteria.
Methods
Protein preparation. The macB gene of A. baumannii was ampliﬁed from geno-
mic DNA (ATCC no. BAA-1710D-5) by the polymerase chain reaction using
KOD-plus-Neo DNA polymerase (TOYOBO, Japan) with the forward
(5′-ggaattccatatgacaaaacaagctttgcttgaagtc-3′) and the reverse (5′-cgggatcct-
tattctcgtgatagtgctgcaacag-3′) primers (Supplementary Table 3), and inserted via
NdeI and BamHI restriction sites into a modiﬁed pET-22 (Novagen) expression
vector. Using this method, an N-terminal hexa-histidine tag was added for pur-
iﬁcation by immobilized metal afﬁnity chromatography. The DNA was sequenced
to ensure that only intended changes were introduced. The resulting plasmid was
transformed into E. coli BL21(DE3) (Novagen) for protein expression. The
transformants were grown in ten 5-L ﬂasks at 37 °C in the Davis minimal med-
ium36 supplemented with 0.2% glucose and 0.1% casamino acid. Expression was
induced for 3 h by the addition of 0.1 mM isopropyl-β-D-thiogalactopyranoside at
an OD610 of 0.6. All subsequent procedures were performed at 4 °C unless indi-
cated otherwise. Cells were collected by centrifugation, resuspended in 50 mM Tris
(pH 7.0), 0.5 mM Na-EDTA, 1 mM MgCl2, and disrupted three times using a
Microﬂuidizer M-110EH (Microﬂuidics Corp., NM, USA) at 15,000 psi. Cell debris
was removed by low-speed centrifugation at 27,000×g for 10 min. To collect
membrane fractions, the supernatant was subjected to ultracentrifugation at
145,000×g for 1 h, and washed with 5 mM Tris (pH 7.0), 0.5 mM EDTA. The
Table 3 Data processing and reﬁnement statistics
ADPβS Se-Met
Data collection
Space group P41212 P41212
Cell dimensions a= b, c (Å) 229.7, 154.6 229.2, 155.6
Wavelength 1.7500 0.9787
Resolution (Å)a 3.40 (3.46–3.40) 3.40 (3.46–3.40)
Rmerge 0.086 (>1.000) 0.091 (>1.000)
<I> /<σ (I)> 27.5 (1.0) 28.2 (2.0)
CC1/2 (0.651) (0.832)
Completeness (%) 99.9 (100.0) 99.6 (100.0)
Redundancy 16.3 (15.8) 8.2 (8.4)
Reﬁnement
Resolution (Å) 3.40 3.40
No. of reﬂections 46,498 57,248
Rwork/Rfree 0.2270 / 0.2571 0.2172 / 0.2500
No. of atoms
Protein 9770 9770
Ligand (ADPβS) 54 —
B factor
Overall 62.2 160.3
R.m.s. deviations
Bond length (Å) 0.004 0.005
Bond angle (degree) 0.819 0.888
aValues in parentheses are for the highest resolution shell
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Fig. 4 Nucleotide-binding sites in MacB dimer. a NBD dimer and b close-up view of an ATP-binding site interacting with ADPβS. Each monomer in dimeric
MacB is coloured in green and red, respectively. Walker A motif in cyan, and carboxy-terminal coupling helix (CH2) in yellow, LSGGQ motif in ABC
signature in orange. The difference Fourier map Fo–Fc (without ADPβS) contoured at 2σ (σ is the root mean square electron density of the map) (shown in
blue cage) and the anomalous difference Fourier map contoured at 4σ (shown in red cage) for phosphor and sulphur atoms of bound ADPβS. Bound ADPβS
is shown in stick representation in a and b with the positions of the C, N, O, P and S atoms indicated by yellow, blue, red, orange and gold, respectively. The
positions of key residues of nucleotide-binding site in b are also shown in stick representation with the position of the C atoms indicated in green. c
Structural comparison of NBDs in different nucleotide-bound states. Side view (top row) and top–down view on NBDs (bottom row). Superimposition of
the right half of NBD dimers of MacB (green) vs. AMP-PNP-bound Sav1866 from S. aureus (PDB accession code: 2ONJ in blue)60, AMP-PNP-bound MsbA
from Salmonella typhimurium (PDB accession code: 3B60 in magenta)10, ADP-bound PglK from C. jejuni (PDB accession code: 5C73 in red)25, closed apo-
form MsbA from V. cholera (PDB accession code: 3B5X in magenta)10 or open apo-form MsbA from E. coli (PDB accession code: 3B5W in magenta)10
(Supplementary Table 1). Attempts to superimpose the Mac-NBD on the NBDs of other ABC transporters, such as ABC importers and heterodimeric ABC
exporters, were less successful due to differences in the number of helices and the distinct conﬁgurations of the NBDs
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plasma membrane was solubilized in 50 mM Tris (pH 7.0) buffer, 10% (v/v) gly-
cerol containing protease inhibitors (Roche) and 2% (w/v) n-undecyl-β-D-malto-
side (UDM, GlyconBiochemicals GmbH, Germany) on ice for 1 h. After a further
step of ultracentrifugation at 145,000×g for 1 h, the detergent-solubilized fraction
was collected and incubated with chelating sepharose resin immobilized with Ni2+
ion at 4 °C for 1 h. The resin was washed with the buffer containing 20 mM Tris
(pH 7.5), 100 mM NaCl, 25 mM imidazole, 10% (v/v) glycerol and 0.05% (w/v)
UDM. The protein was eluted from the afﬁnity resin with the wash buffer plus 300
mM imidazole. The fractions containing MacB were collected, concentrated in
Amicon Stirred Cell (Merck Millipore) with 100 kDa molecular weight cutoff
Omega Ultraﬁltration Membrane Disc Filter (Pall Corporation, USA), and ﬁltered
with Ultrafree-MC GV Centrifugal Filter (Merck Millipore). Further puriﬁcation
was performed by size-exclusion chromatography (Superdex-200 Increase 10/300
GL; GE Healthcare) in the buffer containing 20 mM Tris (pH 7.5), 100 mM NaCl,
10% (v/v) glycerol and 0.05% (w/v) UDM at the ﬂow rate of 0.3 ml min−1 using
AKTA explorer 10 S (GE Healthcare). The peak fractions were collected and
concentrated in the same way as described above to about 24 mg of MacB per ml
for crystallization. Concentration of puriﬁed protein was determined by bicinch-
oninic acid (BCA) protein assay (Thermoﬁsher) with bovine serum albumin as a
standard. The purity of MacB was analysed by SDS-PAGE followed by Coomassie
Brilliant Blue staining.
Crystallization. Adenosine-5′-(β-thio)-diphosphate of 10 mM (ADPβS, Jena
bioscience GmbH, Germany) and 2 mM MgCl2 were added to the puriﬁed protein
and incubate for overnight on ice before crystallization. MacB crystals were grown
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by the sitting drop vapour diffusion technique at 25 °C. The protein solution was
mixed (1:1) with reservoir solution containing 1.2–1.3 M sodium citrate, 100 mM
Na-HEPES (pH 7.2). Crystals were grown within 1 week to optimal size (0.3 ×
0.3 × 0.2 mm3). The concentration of glycerol was gradually increased to 30% (v/v)
by soaking in several steps for optimal cryo-protection. Crystals were picked up
using nylon loops (Hampton Research, CA, USA) for ﬂash-cooling in cold nitrogen
gas from a cryostat (Rigaku, Japan). For Se-methionine labelling, E. coli cells were
grown in M9 minimal medium (L-methionine was replaced with seleno-L-
methionine), and the protein was puriﬁed and crystallized as described for native
protein with the exception of the addition of 2 mM adenosine-5′-triphosphate
(ATP, Nacalaitesque, Japan) instead of 10 mM ADPβS before crystallization.
Data collection and structure determination. Data sets were collected at 100 K
using a Rayonix MX300-HE charge-coupled device detector on the BL44XU
beamline at SPring-8. Diffraction images were processed with the HKL2000
package37. Further processing was carried out with programs from the
CCP4 suite38 and Phenix39, 40. Data collection and structure reﬁnement statistics
are summarized in Table 3. Native data was collected at a wavelength of 1.7500 Å.
The initial phases were obtained by SAD (the single anomalous dispersion method)
using SeMet derivative crystals. The heavy atom sub-structure of 19 selenium
atoms was determined by SHELXD, and initial phases were obtained using
SHELXE and SHARP41, 42, and were used to calculate anomalous Fourier maps
using programs from the CCP4 suite38. Density modiﬁcations with solvent ﬂat-
tening and non-crystallographic averaging to phase improvement was performed
using DM43. Model building was carried out using programs O44 and COOT45.
Chain tracing was aided by the known positions of methionines from the sele-
nomethionine data. Model reﬁnement was conducted using Refmac546 and
Rosetta-Phenix47 and Phenix39, 40. Ramachandran analysis revealed 95.6% in the
favoured region and 0.0% residues in the outliers with a Molprobity48 score of 1.49.
The surface area between the MacB monomers was calculated using QT-PISA
(CCP4 suite)49. Figures were prepared using Molscript50 rendered with Raster3D51,
Chimera52 and PyMOL.
Determination of MIC values. The expression vector pBAD24 containing macA-
macB-tolC genes of A. baumannii, deletion mutants, or E172Q mutant of macB
(Supplementary Table 3), were transformed into E. coli strain W3104 ΔacrABΔ-
macAB53. These expression hosts were additionally transformed with the pRARE2
plasmid, which supplies transfer RNAs for rarely used codons in E. coli. The
pRARE2 plasmid was isolated from Rosetta 2 (Novagen). The minimum inhibitory
concentrations (MICs) of macrolide antibiotics were determined as the con-
centrations that prevented bacterial growth after 30 h incubation at 30 °C on YT-
agar (0.8% tryptone, 0.5% yeast extract, 0.5% NaCl, 1.5% agar, 100 μg ml−1
ampicillin and 34 μg ml−1 chloramphenicol) plates with sequential dilutions,
according to standard protocol recommended by the Clinical and Laboratory
Standards Institute54. To induce protein expression, 2% L-arabinose was added in
the agar plates. Expression of MacA, MacB or TolC in the strains used for MIC
measurements was conﬁrmed by western blotting with anti-MacA polyclonal
(1:8000 dilution), anti-MacB monoclonal (1:500 dilution) or anti-TolC polyclonal
(1:8000 dilution) antibodies as the primary antibody, and horseradish peroxidase
(HRP)-labelled goat anti-rabbit (1:20,000 dilution, cat# 111-035-003, Jackson
ImmunoResearch, USA) or anti-mouse (1:10,000 dilution, cat# 115-035-062,
Jackson ImmunoResearch) IgG antibodies as the secondary antibody.
Truncation of second coupling helix. To express MacB without CH2, a stop
codon was introduced by replacing the Leu655 codon in the macB gene through
the use of an inverse PCR-based site-directed mutagenesis kit using KOD DNA
polymerase (TOYOBO) with the two primers (5′-caaaataa-
gaccctgttgcagcactatcacgag-3′, 5′-ctgcattcttggcaggtaagaagcc-3′) (Supplementary
Table 3) and pBAD24 vector containing macA-macB-tolC genes as a template. The
resulting plasmid was sequenced to conﬁrm successful truncation, and codes for a
truncated MacB protein lacking the C-terminal 10 residues that correspond to
CH2. Expression of this truncated MacB was conﬁrmed by western blotting with
anti-MacB polyclonal antibody (1:1000 dilution) and HRP-labelled goat
anti-rabbit IgG antibody (1:20,000 dilution, cat# 111-035-003, Jackson Immu-
noResearch). The mutant was used for the MIC measurement as well as the wild-
type protein.
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Fig. 6 Structural comparison between MacB vs. Sav1866 and PglK. Ribbon representation of (left) ADP-bound, outward-open conformation of Sav1866
(blue, PDB accession code: 2HYD)9, (middle) ADP bound, outward-occluded conformation of PglK (orange, PDB accession code:5C73)25 and (right)
ADPβS-bound MacB (green), viewed from membrane plane (top) and cytoplasm (bottom). Dotted lines depict the approximate membrane boundaries.
Alfa phosphate atoms of the two bound nucleotides are connected by a magenta line showing the interface in each NBD dimer. For ADP-bound PglK, the
coordinates of ADP were not deposited in the Protein Data Bank25. Outward-facing, V-shaped cavities in the TMDs are depicted as dotted triangles. Elbow
helix and connecting TM1, which contribute to the extent of the external opening in each transporter, are coloured in red
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Measurement of cellular growth rates. Overnight cultures from glycerol-stocks
of drug-hypersensitive E. coli ΔacrAB ΔmacAB, harbouring pBAD plasmid
encoding A. baumannii MacAB-TolC, MacA-TolC (inactive control) or none of
these genes (inactive non-expressing control), were grown in Luria-Bertani broth
containing
100 µg ml−1carbenicillin. Cultures were grown for about 16 h at 37 °C, and then
used to inoculate fresh medium (1:1000 dilution). Once E. coli cells had reached
OD600 of 0.3–0.4, protein production was induced by addition of 2% arabinose for
3 h. The cells were then diluted to OD600 of 0.06 in fresh medium containing 2%
arabinose in the wells of a 96-well plate to which antibiotics were added as indi-
cated in Fig. 1b. Growth was followed over time at OD600 at 37 °C in a Versamax
microplate reader (Molecular Devices, USA).
Data availability. Coordinates and structure factors have been deposited in the
Protein Data Bank with accession codes: 5GKO and 5WS4. Data supporting the
ﬁndings of this study are available within the article and its Supplementary
Information ﬁles. Data have also been deposited in the University of Cambridge
data repository (https://doi.org/10.17863/CAM.12992) or are available from the
corresponding author upon reasonable request.
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